Prospective study of biomarkers predictive of radiation-induced bladder toxicity in patients treated with radiotherapy for localized prostate cancer: RABBIO (Radiotoxicity Bladder BIOmarkers).

Authors

Carole Helissey

Carole Helissey

Clinical Research Unit, Military Hospital Begin, Saint-Mandé, France

Carole Helissey , Sophie Cavallero , Pierre Blanchard , Olivier Bauduceau , Antoine Schernberg , Christos Christopoulos , Ryan Bouaita , Stanislas Mondot , Laurie Monnier , Hosni Popotte , Nadia Besson , Benedicte Durand , Minh Hanh TA , Charles Parnot , Cyrus Chargari , Sabine Francois

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Symptoms and Survivorship

Track

Symptom Science and Palliative Care

Sub Track

Late and Long-Term Adverse Effects

Clinical Trial Registration Number

2021A0319635

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr TPS12142)

DOI

10.1200/JCO.2022.40.16_suppl.TPS12142

Abstract #

TPS12142

Poster Bd #

384a

Abstract Disclosures

Similar Posters

Poster

2020 Genitourinary Cancers Symposium

Late toxicity and quality of life from GETUG-AFU 22 study.

Late toxicity and quality of life from GETUG-AFU 22 study.

First Author: Igor Latorzeff

Poster

2018 Genitourinary Cancers Symposium

Self-reported burden in patients with localized prostate cancer treated with stereotactic body radiation therapy (SBRT).

Self-reported burden in patients with localized prostate cancer treated with stereotactic body radiation therapy (SBRT).

First Author: Abigail Pepin